Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Journal of Dermatology, 2022

DOI: 10.1111/1346-8138.16678

Links

Tools

Export citation

Search in Google Scholar

Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO